Genetic Risk for Alzheimer\u27s Disease Alters the Five-Year Trajectory of Semantic Memory Activation in Cognitively Intact Elders by Rao, Stephen M. et al.
Marquette University
e-Publications@Marquette
Psychology Faculty Research and Publications Psychology, Department of
5-1-2015
Genetic Risk for Alzheimer's Disease Alters the
Five-Year Trajectory of Semantic Memory
Activation in Cognitively Intact Elders
Stephen M. Rao
Neurological Institute
Aaron Bonner-Jackson
Neurological Institute
Kristy A. Nielson
Marquette University, kristy.nielson@marquette.edu
Michael Seidenberg
Rosalind Franklin University of Medicine and Science
J. Carson Smith
University of Maryland - College Park
See next page for additional authors
Accepted version. NeuroImage, Vol. 111 (May 2015): 136-146. DOI. © 2015 Elsevier Inc. Used with
permission.
NOTICE: this is the author’s version of a work that was accepted for publication in NeuroImage.
Changes resulting from the publishing process, such as peer review, editing, corrections, structural
formatting, and other quality control mechanisms may not be reflected in this document. Changes
may have been made to this work since it was submitted for publication. A definitive version was
subsequently published in NeuroImage, Vol. 111 (May 2015): 136-146. DOI.
Authors
Stephen M. Rao, Aaron Bonner-Jackson, Kristy A. Nielson, Michael Seidenberg, J. Carson Smith, John L.
Woodard, and Sally Durgerian
This article is available at e-Publications@Marquette: https://epublications.marquette.edu/psych_fac/173
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
NeuroImage, Vol 111, (May 1, 2015): pg. 136-146. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
1 
 
 
 
Genetic Risk for Alzheimer’s Disease 
Alters the Five-Year Trajectory of 
Semantic Memory Activation in 
Cognitively Intact Elders 
 
  
Stephen M. Rao 
Schey Center for Cognitive Neuroimaging, Lou Ruvo Center for 
Brain Health, Neurological Institute, Cleveland Clinic, 
Cleveland, OH 
Aaron Bonner-Jackson 
Schey Center for Cognitive Neuroimaging, Lou Ruvo Center for 
Brain Health, Neurological Institute, Cleveland Clinic, 
Cleveland, OH 
Kristy A. Nielson 
Department of Psychology, Marquette University, 
fDepartment of Neurology, Medical College of Wisconsin, 
Milwaukee, WI 
Michael Seidenberg 
Department of Psychology, Rosalind Franklin University of 
Medicine and Science, 
North Chicago, IL 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
NeuroImage, Vol 111, (May 1, 2015): pg. 136-146. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
2 
 
J. Carson Smith 
Department of Kinesiology, School of Public Health, 
University of Maryland, 
College Park, MD 
John L. Woodard 
Department of Psychology, Wayne State University, 
Detroit, MI 
Sally Durgerian 
Department of Neurology, Medical College of Wisconsin, 
Milwaukee, WI 
 
 
 
 
Abstract: Healthy aging is associated with cognitive declines typically 
accompanied by increased task-related brain activity in comparison to 
younger counterparts. The Scaffolding Theory of Aging and Cognition (STAC) 
(Park and Reuter-Lorenz, 2009; Reuter-Lorenz and Park, 2014) posits that 
compensatory brain processes are responsible for maintaining normal 
cognitive performance in older adults, despite accumulation of aging-related 
neural damage. Cross-sectional studies indicate that cognitively intact elders 
at genetic risk for Alzheimer’s disease (AD) demonstrate patterns of increased 
brain activity compared to low risk elders, suggesting that compensation 
represents an early response to AD-associated pathology. Whether this 
compensatory response persists or declines with the onset of cognitive 
impairment can only be addressed using a longitudinal design. The current 
prospective, 5-year longitudinal study examined brain activation in APOE ε4 
carriers (N=24) and non-carriers (N=21). All participants, ages 65–85 and 
cognitively intact at study entry, underwent task-activated fMRI, structural 
MRI, and neuropsychological assessments at baseline, 18, and 57 months. 
fMRI activation was measured in response to a semantic memory task 
requiring participants to discriminate famous from non-famous names. 
Results indicated that the trajectory of change in brain activation while 
performing this semantic memory task differed between APOE ε4 carriers and 
non-carriers. The APOE ε4 group exhibited greater activation than the Low 
Risk group at baseline, but they subsequently showed a progressive decline in 
activation during the follow-up periods with corresponding emergence of 
episodic memory loss and hippocampal atrophy. In contrast, the non-carriers 
demonstrated a gradual increase in activation over the 5-year period. Our 
results are consistent with the STAC model by demonstrating that 
compensation varies with the severity of underlying neural damage and can 
be exhausted with the onset of cognitive symptoms and increased structural 
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brain pathology. Our fMRI results could not be attributed to changes in task 
performance, group differences in cerebral perfusion, or regional cortical 
atrophy. 
Keywords: Aging, Alzheimer’s disease, APOE ε4, fMRI, Semantic memory 
Introduction 
Healthy aging is associated with mild and gradual declines in 
cognition functions, with the greatest aging-related changes involving 
memory, processing speed, and visuospatial skills (Salthouse, 2010). 
Such changes often occur in parallel with age-related alterations in 
brain structure, characterized by cortical atrophy and white matter 
abnormalities (Drachman, 2006; Kramer et al., 2007). Paradoxically, 
fMRI studies have consistently found increased regional brain activity 
in healthy elders relative to their younger counterparts during the 
performance of a cognitive task. This increased task-related brain 
activity in healthy elders typically occurs in brain regions also activated 
by younger participants, but can also be observed in homologous 
regions in the opposite hemisphere (Cabeza et al., 2002; Nielson et 
al., 2002, 2006). Some investigators have noted that age-related 
increases in brain activity occur most often in the frontal cortex; for 
reviews and discussion, see (Buckner, 2004; Eyler et al., 2011; 
Nielson et al., 2002). This increased neural activity is thought to serve 
as a compensatory function to support a high level of performance in 
older adults (Bangen et al., 2012; Carp et al., 2010; Grady, 2008; Han 
et al., 2009; Nielson et al., 2002, 2006; Prvulovic et al., 2005; Reuter-
Lorenz and Cappell, 2008; Wierenga et al., 2008). 
One prominent theory, the Scaffolding Theory of Aging and 
Cognition (STAC) (Park and Reuter-Lorenz, 2009), posits that 
compensatory brain processes are responsible for preserving cognitive 
performance in older adults, despite accumulation of neural changes in 
the context of healthy aging (e.g., mild white matter disease, age-
related atrophy). This theory identifies neural factors that contribute to 
maintenance of a specific level of cognitive function and does not 
address dynamic longitudinal changes occurring during the aging 
process. More recently, these authors (Reuter-Lorenz and Park, 2014) 
revised the STAC theory (STAC-r) to account for both positive (e.g., 
physical activity) and negative (e.g., presence of brain amyloid) 
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factors that contribute to the rate of change in cognitive function 
during aging. This revision provides a framework for tracking the 
trajectory of neural compensation (scaffolding) in response to rate of 
change in cognitive processes, but empirical validation of the theory is 
dependent on imaging data derived from extended longitudinal 
imaging studies. 
In the current prospective, 5-year longitudinal fMRI study, we 
examined compensatory neural scaffolding processes in cognitively 
intact elders at varying genetic risk for developing Alzheimer’s disease 
(AD). The most important genetic risk factor for the sporadic form of 
AD (onset occurring after age 65) is the apolipoprotein E epsilon 4 
(APOE ε4) allele (Farrer et al., 1997). Cross-sectional fMRI studies 
from our group (Seidenberg et al., 2009; Smith et al., 2011; Woodard 
et al., 2009, 2010) and others (Bookheimer et al., 2000; Borghesani 
et al., 2008; Filippini et al., 2011; Han et al., 2007; Trachtenberg et 
al., 2012; Wierenga and Bondi, 2007; Wierenga et al., 2010) have 
consistently demonstrated greater brain activation (neural scaffolding) 
in cognitively intact elders at higher genetic risk for AD (based on the 
presence of one or both APOE ε4 alleles and/or a family history of AD) 
than elders at lower genetic risk. Presumably, this increased activation 
occurs because the neuropathological changes associated with AD 
begin years or decades prior to symptom manifestation in persons at 
genetic risk for AD (Bateman et al., 2012; Jack et al., 2010). Indeed, 
alterations in task-related brain activity and cognitive performance 
have been reported in cross-sectional studies of APOE-ε4 positive 
individuals beginning in middle age and earlier (Evans et al., 2014; 
Reiman et al., 2004). 
For this study, we recruited cognitively intact elders, APOE ε4 
carriers and non-carriers, who underwent repeat cognitive testing, 
structural MRI, and task-activated fMRI on three occasions: study 
entry, 18 and 57 months. The fMRI task consisted of the Famous 
Name Recognition Task (FNRT) (Douville et al., 2005), a low-effort 
semantic memory task. The FNRT is performed with high accuracy 
even in patients with amnestic mild cognitive impairment (Woodard et 
al., 2009), thus removing high effort/low accuracy from complicating 
the interpretation of the longitudinal brain maps (Kennedy et al., 
2014). Previous cross-sectional studies (Nielson et al., 2006, 2010; 
Seidenberg et al., 2009; Woodard et al., 2010) using this task have 
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demonstrated a highly reproducible pattern of brain activation in 
regions that overlap with regions that comprise the “default-mode 
network” (Nielson et al., 2010; Sugarman et al., 2012). 
Based on the STAC-r model, we hypothesized that the 
cognitively intact APOE ε4 carriers would exhibit greater task-related 
brain activation than non-carriers at study entry, presumably reflecting 
a compensatory response that may signal subsequent cognitive decline 
(Miller et al., 2008). Over time, however, a breakdown of neural 
scaffolding in the APOE ε4 carrier group is predicted to occur, 
characterized by the presence of age-inappropriate cognitive 
impairment. Decreased brain activity occurs in association with 
increased AD-related neural pathology (O’Brien et al., 2010) and is 
predicted to coincide with decreased episodic memory performance. 
Conversely, non-carriers, who maintain intact and stable episodic 
memory over the course of the 5 year follow-up period, should show a 
steady increase in brain activation reflecting the increasing demands of 
their scaffolding system to maintain memory performance with 
advancing age. 
Material and methods 
Participants 
This study was approved by the Institutional Review Board of 
the Medical College of Wisconsin, which oversees the ethical standards 
of human research. Written informed consent was obtained from all 
subjects included in this study. All participants received financial 
compensation. 
The recruitment strategy for this study, described in detail in 
Seidenberg et al. (2009), involved over-sampling persons at genetic 
risk for AD based on the presence of an APOE ε4 allele. Briefly, healthy 
older adults between the ages of 65 and 85 were recruited from 
newspaper advertisements. A telephone screen, used to determine 
study eligibility, was administered to 459 individuals. Participants were 
excluded if they reported a history of neurological disease, medical 
illnesses, major psychiatric disturbance meeting DSM-IV Axis I criteria, 
a Geriatric Depression Scale [GDS; (Yesavage et al., 1982)] score 
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>20, Lawton Instrumental Activities of Daily Living [IADL; (Lawton and 
Brody, 1969)] scale <5, substance abuse meeting DSM-IV Axis I 
criteria, or were currently taking psychoactive medications. Additional 
exclusion criteria related to fMRI scanning included pregnancy, weight 
inappropriate for height, ferrous objects within the body, low visual 
acuity, and a history of claustrophobia. For purposes of fMRI scanning, 
only right-handed participants were included based on the Edinburgh 
Handedness Inventory (Oldfield, 1971). Of the individuals meeting 
inclusion/exclusion eligibility criteria, 109 agreed to undergo APOE 
genotype testing from blood samples, neuropsychological evaluation, 
and an fMRI scanning session. APOE genotype was determined using a 
polymerase chain reaction method. DNA was isolated with Gentra 
Systems Autopure LS for Large Sample Nucleic Acid Purification 
(O’Brien et al., 2001). Of the 109 enrolled participants, we excluded 
31 participants with a family history of AD but without an APOE ε4 
allele. 
Of the remaining 78 participants, 33 were excluded because 
they were unable to complete all three testing sessions (baseline, 18, 
and 57 months) due to the following reasons: death (6), lost to follow-
up (4), moved away (3), refusal (6), medical contraindications for MR 
scanning (6), MR scanner upgrade at 57months preventing comparison 
with baseline and 18-month scans (7), and motion corruption of MR 
scan (1). The final sample consisted of 45 participants divided into two 
groups: 1) APOE ε4 group (n = 24; mean age = 72.5 years. [SD = 
4.1]; mean education = 15.7 years. [SD = 3.2]; 19 females [79%]) 
who were carriers of one or both ε4 alleles (22 ε3/ε4; 2 ε4/ε4) and 2) 
Low Risk group (n = 21; mean age = 73.2 years. [SD = 5.3]; mean 
education = 14.1 year. [SD = 1.8]; 17 females [81%]) who did not 
possess an APOE ε4 allele (1 ε2/ε3; 20 ε3/ε3). In the APOE ε4 group, 
17 participants (70.8%) had a family history of dementia, while no 
participant in the Low Risk group had a family history of dementia. No 
significant group differences were observed for age or gender; a 
significant group difference in education, reflecting more years of 
education in the APOE ε4 group, was observed (p= 0.04). 
For each session, neuropsychological testing and MR scanning 
were conducted on the same day. Participants were asked to refrain 
from alcohol use 24 h and caffeine use 12 h prior to testing. The 
neuropsychological test battery consisted of the Mini-Mental State 
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Examination (Folstein et al., 1975), Mattis Dementia Rating Scale 2 
[DRS-2; (Jurica et al., 2001)], and Rey Auditory Verbal Learning Test 
[RAVLT; (Rey, 1958)]. Alternate, equivalent test forms were used at 
each session to minimize practice effects. 
Participants were evaluated for the presence of Mild Cognitive 
Impairment (MCI) or AD at the two follow-up sessions. The diagnosis 
of MCI and AD was based on a multidisciplinary consensus conference 
that reviewed each participant’s medical history and social history 
since the previous examination, cognitive test results, and activities of 
daily living competency. Each participant was queried regarding 
cognitive complaints (e.g., memory, planning ability, attention, 
language). If a complaint was expressed, performance on the DRS-2 
and RAVLT was compared to an age-adjusted normative database; 
scores 1.5 SD below the mean on one or more subscales indicated 
MCI, as long as no functional impairment was reported on the IADL 
scale. If IADL scores were in the abnormal range (<5), a diagnosis of 
AD was made. No participant met the criteria for AD during the study 
period. 
Imaging 
MRI acquisition  
Whole-brain, event-related fMRI was conducted on a General 
Electric (Waukesha, WI) Signa Excite 3.0 Tesla short bore scanner 
equipped with a quad split quadrature transmit/receive head coil. 
Echoplanar images were collected using an echoplanar pulse sequence 
(TE = 25 ms; flip angle = 77°; field of view (FOV) = 24 mm; matrix 
size = 64 × 64). Thirty-six contiguous axial 4-mm-thick slices were 
selected to provide coverage of the entire brain (voxel size = 3.75 × 
3.75 × 4 mm). The interscan interval (TR) was 2 s. 
High-resolution, three-dimensional spoiled gradient-recalled at 
steady-state (SPGR) anatomic images were acquired (TE = 3.9 ms; TR 
= 9.5 ms; inversion recovery (IR) preparation time = 450 ms; flip 
angle = 12°; number of excitations (NEX) = 2; slice thickness = 1.0 
mm; FOV = 24 cm; resolution = 256 × 224). 
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Perfusion images were collected at the 57 month follow-up using 
pseudocontinuous ASL (pCASL) (Dai et al., 2008), using an echoplanar 
pulse sequence (flip angle=90°; field of view (FOV)=240mm; matrix 
size = 64 × 64). Scans were collected as two volumes (inferior and 
superior), each consisting of 12 axial 5-mm-thick slices (+1 mm skip), 
selected to provide whole brain coverage (voxel size = 3.75 × 3.75 × 
4mm, TR=4 s, reps=90). In order to register the two volumes, a 
whole brain image of 24 slices was acquired (slices = 24, TR = 4 s, 
reps = 6). Foam padding was used to reduce head movement within 
the coil. 
fMRI task  
The task stimuli consisted of 30 names of famous persons and 
30 names of unfamiliar individuals selected from an original pool of 
784 names because of a high rate of identification (>90% correct; 
(Douville et al., 2005)). A trial consisted of the visual presentation of a 
single name for 4 s. Participants were instructed to make a right index 
finger key press if the name was famous and a right middle finger key 
press if the name was not famous. The 60 name trials were randomly 
interspersed with 30 4-sec. trials in which the participant was 
instructed to fixate on a single centrally placed crosshair. This 
condition was performed in order to introduce “jitter” into the fMRI 
time course. The imaging run began and ended with 12 s of fixation. 
Total time for the single imaging run was 5 min and 24 s. 
Accuracy (% correct) and reaction time (RT) were recorded for 
identification of Famous Names and rejection of Non-Famous Names. 
In addition, a signal detection index of discriminability (d′) (Aaronson 
and Watts, 1987; Grier, 1971) was calculated along with a measure of 
intraindividual variability (IIV) calculated from the standard deviation 
of the Famous and Non-Famous RTs for each participant and time 
interval. 
fMRI image analysis  
Functional images were generated with the Analysis of 
Functional NeuroImages (AFNI) software package (Cox, 1996). fMRI 
time series data were time-shifted to coincide with the beginning of 
the TR, motion corrected, transformed to Talairach space, normalized 
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to a whole brain average signal of 10,000, and Gaussian spatial 
filtered to 6 mm FWHM. 
The hemodynamic response (HDR) was deconvolved using 
ordinary least squares regression with an impulse response model 
from stimulus onset to 16 s post-stimulus-onset, using regressors for 
three types of trials: famous names correct, non-famous names 
correct, and incorrect. Hemodynamic responses were shifted so that 
stimulus onset was 0. The unfamiliar names’ HDR was subtracted from 
the famous names’ HDR. The Famous-Non-Famous contrast was 
summarized by summing the points at 4, 6 and 8 s post-stimulus-
onset (peak of the HDR curve). 
The first phase of the fMRI analysis examined the spatial extent 
of neural activation with voxelwise t-tests performed on the Famous-
Non-Famous Names subtraction for each group at each session. A 
voxel was deemed “active” with the following threshold: individual 
voxel p < 0.005 and minimum cluster volume >0.731 ml. These 
values were determined from a Monte Carlo simulation producing a 
familywise error of identifying a significant cluster at p < 0.05 (Cox, 
1996). 
The second analytic phase involved the identification of 
functional regions of interest (fROI). A disjunction mask was derived 
from the voxelwise maps generated in the previous phase. Any voxel 
deemed “significant” in any of the groups and at any of the scan 
sessions was included in the fROI map. For each participant and time 
period, the fMRI signal change was averaged across voxels within each 
fROI. 
The resulting longitudinal fROI data were fit to a linear mixed 
effects (LME) model using R version number 3.0.2 (Team, 2008). LME 
modeling has a number of advantages over a traditional repeated 
measures analysis of variance (ANOVA) (Singer and Willett, 2003). 
First, LME permits the modeling of the actual time intervals between 
repeated assessments, whereas repeated measures ANOVA assumes 
equal intervals between evaluations. In this study, our intervals 
between evaluations were 18 and 57 months, necessitating the use of 
an analytic technique that can model these unequally spaced time 
intervals. Furthermore, LME permits the use of the actual number of 
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days between scans as the time variable for individual subjects. 
Second, LME permits an unequal number of within-subject 
observations, making this technique quite flexible in cases where 
missing data may occur. In contrast, repeated measures ANOVA 
requires all participants to have observations at each measurement 
point. If a participant has a single missing data point, that participant 
could not be included in the repeated measures analysis. 
The level one random effects model for this analysis consisted of 
a linear within-subject model of fMRI activation as a function of weeks 
post baseline. The level two fixed effects model estimated the slope 
and intercept of fMRI activation across groups and weeks post 
baseline, where the Low Risk group provided the base model and the 
APOE ε4 group differences were modeled with respect to the Low Risk 
group. Residuals were visually inspected using quantile–quantile plots 
to confirm the assumption of normality. A quadratic model was also 
considered, but comparison of the Akaike Information Criterion (AIC) 
for each model showed that the linear model was preferred. 
Perfusion IMAGING  
AFNI was used to process the perfusion data. Each subject’s 
whole brain perfusion image was aligned to the fMRI data. After 
discarding the first four images, each of the two perfusion volumes 
was corrected for head motion. For each tagged image in the time 
series, the preceding and subsequent untagged images were 
averaged, and this control image was subtracted from its respective 
tagged image. All volumes in the tagged-control time series were 
averaged (t-c), as were all volumes in the control time series (c). 
Voxelwise blood flow was calculated using Eq. (1) in Wang et al. 
(2005), with duration of labeling pulse = 1.5 s, post-labeling delay 
time=1 s and tagging efficiency=0.95. To obtain whole brain voxelwise 
blood flow data, each of the two volumes was aligned to the realigned 
whole brain volume and combined, using average values for any 
overlapping voxels, and transformed to Talairach space. Average blood 
flow for each of the fROIs was extracted, and each region for the two 
groups was compared using a two-sample Welch’s t-test. 
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Hippocampal volume  
The left and right hippocampal volumes were measured from 
T1-weighted SPGR images using longitudinal Free surfer v.5.1 (Reuter 
et al., 2012) applied to all three scan sessions. No significant 
differences were observed between the left and right hippocampal 
volumes, so they were summed to create a single bilateral volume, 
which was normalized by dividing by the total intracranial volume. 
Cortical thickness  
Volume-defined cortical fROIs (see fMRI Image Analysis section) 
were projected onto the longitudinal Free surfer surfaces for each 
subject and scan session Mean cortical thickness was extracted for 
each of the fROIs on the cortical surface 
(https://surfer.nmr.mgh.harvard.edu/fswiki/VolumeRoiCorticalThickne
ss). ROI cortical thickness measurements were subjected to the 
identical LME analysis as applied to the fMRI data. 
Results 
No group differences were observed in the time interval (in 
months) between the baseline and second session (Low Risk = 18.4, 
SD = 1.7; APOE ε4=18.2, SD=0.6) and between the baseline and the 
third session (Low Risk=58.0, SD=2.1; APOE ε4=56.4, SD=4.3). No 
significant group differences were observed for baseline 
neuropsychological testing, fMRI task performance, or hippocampal 
volume (Table 1). 
Table 1. Baseline characteristics of Low Risk and APOE ε4 groups. 
Variable Low Risk (n = 21) APOE e4 (n = 24) p* Cohen’s d 
MMSE 29.29 (0.85)** 29.21 (0.98) 0.78 0.08 
DRS-2 memory 24.29 (0.96) 24.04 (1.60) 0.53 0.18 
DRS-2 total 141.05 (1.99) 140.33 (3.60) 0.41 0.24 
RAVLT delayed recall 9.90 (2.14) 9.75 (2.92) 0.84 0.06 
RAVLT trials 1–5 49.33 (8.39) 48.50 (8.17) 0.74 0.10 
fMRI task 
 Famous (% correct) 93.97 (5.23) 91.39 (7.54) 0.19 0.39 
 Non-famous (% correct) 95.87 (5.76) 97.78 (3.63) 0.20 −0.40 
 d′ 3.29 (0.64) 3.32 (0.62) 0.85 −0.06 
 Famous (RT, msec) 1236 (180) 1249 (151) 0.81 −0.07 
 Non-famous (RT, msec) 1622 (354) 1578 (358) 0.68 0.13 
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Variable Low Risk (n = 21) APOE e4 (n = 24) p* Cohen’s d 
 IIV famous (RT) 351 (90) 371 (131) 0.57 −0.17 
 IIV non-famous (RT) 347 (101) 330 (94) 0.56 0.18 
Hippocampal volume (% ICV) 0.47 (0.06) 0.46 (0.07) 0.63 0.14 
MMSE = Mini Mental State Examination; DRS-2 = Dementia Rating Scale-2; RAVLT = 
Rey Auditory Verbal Learning Test; RT = reaction time; IIV= intraindividual variability 
based on the average standard deviation of RTs for correct responses; % ICV = 
percent intracranial volume. 
*p-Values derived from Student t-test, except for gender (Fischer’s exact test). 
**Mean (standard deviation). 
Table 2 summarizes LME analysis applied to neuropsychological 
testing, fMRI task performance, and hippocampal volume. No 
significant differences in the intercept (baseline) were observed 
between the Low Risk and APOE ε4 groups on these variables. 
Likewise, no changes over time (slope) were observed in 
neuropsychological testing, fMRI task performance, or hippocampal 
volume in the Low Risk group with the exception of a reduction in RT 
for the Non-Famous Names condition. Significant differences in slope 
were detected in the APOE ε4 group relative to the Low Risk group for 
a measure of episodic memory (RAVLT Delayed Recall) and 
hippocampal volume, with a pronounced decline observed in the APOE 
ε4 group over time (Fig. 1). No other differences in slope were 
detected between the Low Risk and APOE ε4 groups. Performance on 
the fMRI task remained above 88% correct for all groups and sessions 
(chance = 50%). 
 
Fig. 1. Longitudinal changes in RAVLT Delayed Recall (left) and ICV-corrected 
hippocampal volume (right) for the Low Risk and APOE ε4 groups at baseline (0 
months), 18 months, and 57 months. 
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Table 2. Coefficients from linear mixed effects analysis of neuropsychological 
test scores, fMRI task performance, and hippocampal volume. 
Variable 
Intercept (baseline)  
 
Slope (time)  
 
Low Riska 
APOE ε4 vs. Low 
Riskb 
Low Riskc 
APOE ε4 vs. Low 
Riskd 
MMSE 29.35 
(0.18) 
0.014 (0.246) 0.004 (.007) −0.014 (.009) 
DRS-2 memory 24.30 
(0.27) 
−0.597 (0.367) 0.008 (.008) −0.019 (.011) 
DRS-2 total 140.19 
(0.58) 
−0.717 (0.790) 0.007 (.016) −0.019 (.022) 
RAVLT delayed recall 9.63 (0.56) −0.397 (0.770) 0.006 (.011) −0.036 (.015) 
RAVLT trials 1–5 48.84 
(1.71) 
−1.515 (2.339) −0.005 (.032) −0.028 (.044) 
fMRI task 
 Famous (% correct) 94.46 
(1.27) 
−2.479 (1.738) −0.099 
(0.054) 
0.026 (0.074) 
 Non-famous (% 
correct) 
96.91 
(1.09) 
1.456 (1.498) −0.113 
(0.071) 
−0.030 (0.097) 
 d′ 3.38 (0.12) −0.011 (0.162) −0.007 
(0.005) 
−0.003 (0.006) 
 Famous (RT, msec) 1248.0 
(36.0) 
−0.893 (49.339) −1.034 
(0.757) 
1.688 (1.046) 
 Non-famous (RT, 
msec) 
1628.1 
(74.1) 
−46.960 (101.430) −3.425 
(1.675) 
3.997 (2.304) 
 IIV famous (RT, 
msec) 
353.4 
(23.0) 
10.622 (31.475) −0.237 
(0.408) 
0.532 (0.564) 
 IIV non-famous (RT, 
msec) 
338.3 
(21.4) 
−5.952 (29.308) −0.438 
(0.593) 
1.394 (0.817) 
Hippocampal volume (% 
ICV) 
0.47 (0.01) −0.0100 (0.0203) −0.0001 
(0.0001) 
−0.0003 (0.0001) 
Bolded values are statistically significant at p < 0.05. 
MMSE=MiniMental State Examination; DRS-2=Dementia Rating Scale-2; RAVLT=Rey 
Auditory Verbal Learning Test; RT=reaction time; IIV=intraindivual variability based 
on the average standard deviation of RTs for correct responses; % ICV = percent 
intracranial volume. 
aPredicted mean intercept (baseline) value of each dependent variable for the Low Risk 
group. All values are statistically significant from 0. 
bPredicted difference between mean intercept (baseline) values for the Low Risk group 
and the APOE ε4 group. 
cPredicted average monthly rate of change (slope) for the Low Risk group. 
dPredicted difference in the average monthly rate of change (slope) between the Low 
Risk group and the APOE ε4 group. Standard errors of coefficients are in parentheses. 
Fig. 2 presents the results of the voxelwise analysis 
demonstrating changes in spatial extent of activation for the two 
groups over the three sessions. This figure demonstrates a pattern of 
increasing spatial extent of activation in the Low Risk group over time 
and decreasing spatial extent in the APOE ε4 group. 
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Fig. 2. Voxelwise subtraction of the Famous and Non-Famous Name hemodynamic 
response functions for the Low Risk and APOE ε4 groups at baseline (0 months), 18 
months, and 57 months. 
To test this observation, a fROI disjunction mask was created 
from the voxelwise analysis (see Materials and methods section) and 
resulted in 16 regions shown in Fig. 3. Table 3 summarizes the LME 
analysis applied to the 16 fROIs. Intercept analysis indicated that the 
APOE ε4 group demonstrated greater activation at baseline than the 
Low Risk group in 10 of 16 fROIs. The Low Risk group demonstrated a 
significant increase in activation over time (slope) in 4 fROIs. The 
APOE ε4 group demonstrated a significant decline over time (slope) 
relative to the Low Risk group in 10 of 16 fROIs. Fig. 4 plots the 
longitudinal activation changes in these 10 regions. A crossover in 
activation was observed, characterized by greater activation of the 
APOE ε4 group relative to the Low Risk group at baseline that 
subsequently declined over time. In contrast, activation in the Low 
Risk group was lower than the APOE ε4 group at baseline but gradually 
increased over time. 
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Fig. 3. Functional regions of interest (fROIs) generated from a disjunction mask 
derived from the Low Risk and APOE ε4 groups at baseline (0 months), 18 months, 
and 57 months (see Methods). fROI region numbers correspond to numbers in Tables 
3–5. BA= Brodmann’s areas; R= right, L= left, B = bilateral; SMA = supplementary 
motor area. 
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Fig. 4. Percent MR signal intensity derived from subtraction of Famous and Non-
Famous Names for 10 fROIs demonstrating significant differences between the Low 
Risk and APOE ε4 groups in slope (see Table 3). Numbers in brackets correspond to 
fROIs described in Fig. 3. 
 
Table 3. Coefficients from linear mixed effects analysis of functional ROIs 
from famous name recognition task. 
No. Side Region 
Intercept (baseline)  
 
Slope (time)  
 
Low Risk a 
APOE ε4 vs 
Low Risk b 
Low Risk c 
APOE ε4 vs 
Low Risk d 
1 B Precuneus, posterior 
cingulate cortex 
0.2610 
(0.0828) 
0.2537 
(0.1135) 
0.0029 
(0.0024) 
−0.0078 
(0.0033) 
2 L Middle temporal, angular 
gyri 
0.2381 
(0.0552) 
0.1839 
(0.0756) 
0.0012 
(0.0016) 
−0.0061 
(0.0022) 
3 R Middle temporal, angular 
gyri 
0.0875 
(0.0520) 
0.2360 
(0.0712) 
0.0030 
(0.0014) 
−0.0066 
(0.0020) 
4 L Middle, superior frontal 
gyri 
0.2299 
(0.0575) 
0.1063 
(0.0788) 
−0.0002 
(0.0017) 
−0.0041 
(0.0024) 
5 L Inferior & middle 
occipital, fusiform gyri 
−0.2994 
(0.0586) 
0.2578 
(0.0802) 
0.0071 
(0.0017) 
−0.0090 
(0.0024) 
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No. Side Region 
Intercept (baseline)  
 
Slope (time)  
 
Low Risk a 
APOE ε4 vs 
Low Risk b 
Low Risk c 
APOE ε4 vs 
Low Risk d 
6 L Caudate nucleus 0.0448 
(0.0661) 
0.3274 
(0.0905) 
0.0027 
(0.0021) 
−0.0080 
(0.0029) 
7 R Superior medial gyrus, 
SMA 
−0.3366 
(0.0638) 
0.1339 
(0.0874) 
0.0033 
(0.0020) 
−0.0027 
(0.0027) 
8 R Superior occipital gyrus −0.2401 
(0.0638) 
0.2303 
(0.0875) 
0.0037 
(0.0018) 
−0.0037 
(0.0025) 
9 R Inferior occipital gyrus −0.2962 
(0.0565) 
0.3126 
(0.0773) 
0.0055 
(0.0017) 
−0.0086 
(0.0023) 
10 R Fusiform, lingual gyri −0.1653 
(0.0811) 
0.5732 
(0.1111) 
0.0081 
(0.0026) 
−0.0160 
(0.0035) 
11 L Fusiform, lingual gyri −0.3607 
(0.0836) 
0.5036 
(0.1145) 
0.0107 
(0.0025) 
−0.0145 
(0.0035) 
12 L Cerebellum (VII–VIII) −0.00844 
(0.0843) 
0.4364 
(0.1154) 
0.0041 
(0.0024) 
−0.0128 
(0.0033) 
13 L Superior medial gyrus, 
anterior cingulate 
0.3442 
(0.1038) 
0.0979 
(0.1422) 
−0.0009 
(0.0028) 
−0.0044 
(0.0038) 
14 R Hippocampus 0.0990 
(0.0708) 
0.2039 
(0.0970) 
0.0030 
(0.0020) 
−0.0082 
(0.0027) 
15 L Hippocampus 0.3171 
(0.1064) 
−0.0314 
(0.1458) 
0.0003 
(0.0032) 
−0.0017 
(0.0044) 
16 L Parahippocampal, 
fusiform gyri 
0.1142 
(0.1156) 
0.3340 
(0.1584) 
0.0047 
(0.0034) 
−0.0089 
(0.0047) 
Bolded values are statistically significant after control for multiple comparisons using 
false discovery rate. SMA = supplementary motor area. 
aPredicted mean intercept (baseline) value of each dependent variable for the Low Risk 
group. 
bPredicted difference between mean intercept (baseline) values for the Low Risk group 
and the APOE ε4 group. 
cPredicted average monthly rate of change (slope) for the Low Risk group. 
dPredicted difference in the average monthly rate of change (slope) between the Low 
Risk group and the APOE ε4 group. Values are percent signal change. 
No participant was diagnosed with AD or any other form of 
dementia over the course of the study. At the 57-month follow-up, 8 
of 24 APOE ε4 carriers (33.3%) converted to MCI, whereas only one 
noncarrier (4.8%)was diagnosed with MCI. This group difference was 
statistically significant (Fisher’s exact test, p = 0.027). 
In light of the higher rate of conversion to MCI in the APOE ε4 
group, it is conceivable that the decrease in brain activation pattern in 
this group was due to cortical atrophy. Table 4 summarizes the LME 
analysis applied to 13 cortical fROIs. The Low Risk group demonstrated 
an increase in cortical thickness in three fROIs over time. Importantly, 
the rate of change in cortical thickness was not different between the 
APOE ε4 carrier and non-carrier groups. 
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Table 4. Coefficients from linear mixed effects analysis of cortical thickness in 
functional ROIs. 
o. Side Region 
Intercept (baseline) Slope (time) 
Low 
Risk a 
APOE ε4 vs. 
Low Risk b 
Low Risk c 
APOE ε4 vs. 
Low Risk d 
1 B Precuneus, posterior 
cingulate cortex 
2.532 
(.024) 
0.0434 (.0331) 0.0006 
(.0003) 
−0.0004 (.0004) 
2 L Middle temporal, angular 
gyri 
2.502 
(.028) 
0.0223 (.0378) −0.0003 
(.0003) 
−0.0008 (.0004) 
3 R Middle temporal, angular 
gyri 
2.490 
(.030) 
0.0524 (.0408) −0.0001 
(.0003) 
−0.0009 (.0004) 
4 L Middle, superior frontal gyri 2.349 
(.034) 
0.0297 (.0469) 0.0012 
(.0005) 
−0.0009 (.0007) 
5 L Inferior & middle occipital, 
fusiform gyri 
1.976 
(.033) 
0.0223 (.0460) 0.0006 
(.0004) 
−0.0006 (.0006) 
7 R Superior medial gyrus, SMA 2.649 
(.040) 
0.0413 (.0475) 0.0007 
(.0004) 
−0.0004 (.0006) 
8 R Superior occipital gyrus 2.014 
(.035) 
0.0413 (.0475) 0.0003 
(.0004) 
−0.0006 (.0006) 
9 R Inferior occipital gyrus 1.99 
(.044) 
0.0346 (.0599) 0.0005 
(.0005) 
−0.0002 (.0007) 
10 R Fusiform, lingual gyri 2.064 
(.041) 
0.0591 (.0555) 0.0011 
(.0004) 
−0.0016 (.0006) 
11 L Fusiform, lingual gyri 2.136 
(.043) 
−0.0112 (.0583) 0.0015 
(.0005) 
−0.0013 (.0007) 
13 L Superior medial gyrus, 
anterior cingulate 
2.517 
(.082) 
0.2154 (.1125) 0.0028 
(.0009) 
−0.0032 (.0011) 
16 L Parahippocampal, fusiform 
gyri 
2.296 
(.085) 
0.1826 (.1165) 0.0007 
(.0008) 
−0.0014 (.0011) 
Standard errors of coefficients are in parentheses. 
Bolded values are statistically significant after control for multiple comparisons using 
false discovery rate. 
aPredicted mean intercept (baseline) value of each dependent variable for the Low Risk 
group. Though these values are statistically significant, they’re not indicated in bold 
text. 
bPredicted difference between mean intercept (baseline) values for the Low Risk group 
and the APOE ε4 group. 
cPredicted average monthly rate of change (slope) for the Low Risk group. 
dPredicted difference in the average monthly rate of change (slope) between the Low 
Risk group and the APOE ε4 group. Unless otherwise specified, values are cortical 
thickness in millimeters. 
The fMRI results could be affected by changes in neurovascular 
coupling associated with AD pathology, presumed to be greater in 
APOE ε4 carriers. Resting cerebral blood flow was measured using ASL 
in the 16 fROIs during the 57-month follow-up session. Table 5 
indicates that there were no significant differences in blood flow 
between the Low Risk and APOE ε4 groups for any of the fROIs. 
Furthermore, resting blood flow did not correlate with fMRI activation 
in any of the fROIs after correction for multiple comparisons. 
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Table 5. Arterial spin labeling measurements of blood flow conducted at 57-
month follow-up. 
 Side Region 
Blood flow Correlation of fMRI activation 
with blood flow  
 
Low Risk APOE ε4 
   
Low 
Risk 
APOE 
ε4 
p* 
Cohen’
s d 
r** p r** p 
1 B Precuneus, 
posterior 
cingulate cortex 
31.16 
(13.50)**
* 
30.20 
(9.58) 
0.6
9 
0.10 0.00 0.98 −0.13 0.26 
2 L Middle 
temporal, 
angular gyri 
25.87 
(8.68) 
25.43 
(8.34) 
0.7
2 
0.09 −0.02 0.90 −0.14 0.24 
3 R Middle 
temporal, 
angular gyri 
30.89 
(13.14) 
28.75 
(8.18) 
0.3
7 
0.22 −0.09 0.48 0.00 1.00 
4 L Middle, superior 
frontal gyri 
20.57 
(10.08) 
20.25 
(10.00
) 
0.8
5 
0.05 −0.15 0.26 0.01 0.90 
5 L Inferior & 
middle occipital, 
fusiform gyri 
14.66 
(7.77) 
13.09 
(7.59) 
0.4
4 
0.20 0.08 0.55 −0.08 0.51 
6 L Caudate nucleus 19.74 
(8.15) 
17.56 
(5.27) 
0.3
7 
0.21 −0.18 0.16 0.16 0.17 
7 R Superior medial 
gyrus, SMA 
21.42 
(8.87) 
23.02 
(7.66) 
0.5
3 
0.16 −0.24 0.06 0.07 0.54 
8 R Superior 
occipital gyrus 
20.12 
(12.46) 
18.80 
(9.36) 
0.6
2 
0.13 −0.03 0.80 −0.05 0.65 
9 R Inferior occipital 
gyrus 
20.18 
(20.18) 
15.86 
(10.99
) 
0.3
4 
0.24 0.01 0.92 −0.24 0.04 
1
0 
R Fusiform, 
lingual gyri 
27.15 
(11.84) 
25.34 
(13.90
) 
0.6
2 
0.15 0.17 0.18 0.10 0.38 
1
1 
L Fusiform, 
lingual gyri 
25.22 
(14.03) 
23.45 
(11.67
) 
0.4
8 
0.19 −0.02 0.86 0.03 0.79 
1
2 
L Cerebellum 
(VII–VIII) 
12.32 
(17.51) 
9.10 
(7.13) 
0.3
9 
0.20 −0.10 0.45 −0.14 0.24 
1
3 
L Superior medial 
gyrus, anterior 
cingulate 
27.48 
(8.45) 
28.34 
(8.46) 
0.8
1 
0.06 −0.08 0.55 −0.04 0.71 
1
4 
R Hippocampus 21.49 
(11.85) 
22.95 
(9.31) 
0.7
6 
0.08 −0.02 0.89 0.22 0.07 
1
5 
L Hippocampus 29.25 
(15.00) 
32.05 
(14.63
) 
0.6
5 
0.13 −0.15 0.26 0.19 0.12 
1
6 
L Parahippocampa
l, fusiform gyri 
30.56 
(18.12) 
33.52 
(19.33
) 
0.7
0 
0.12 −0.22 0.08 −0.18 0.13 
ASL blood flow values are ml/100 g/min. 
SMA = supplementary motor area. 
*p-Values derived from Welch’s t-test. 
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**Pearson correlations between fMRI activation and ASL blood flow (within group). 
***Mean (standard deviation). 
Discussion 
In this study, we investigated the longitudinal trajectory of 
semantic memory activation over a 5-year period among APOE ε4 
carriers and non-carriers. At baseline, the non-carrier group showed 
uniformly lower task-related activation during the semantic memory 
paradigm compared to the APOE ε4 carriers. Over the 5-year interval, 
however, functional activation steadily decreased in multiple regions of 
interest in the APOE ε4 carriers, particularly in posterior cortical areas 
commonly associated with the default mode network (Raichle et al., 
2001). In contrast, the non-carrier group demonstrated a consistent 
increase in activation in the same regions over the same time frame. 
Overall, our results provided evidence in support of differential 
longitudinal trajectories for task-related brain activation as a function 
of genetic risk for development of AD. The findings provide support for 
the STAC-r theory that attempts to account for differences in the 
trajectory of neural compensatory scaffolding associated with changes 
in cognitive performance over time (Reuter-Lorenz and Park, 2014). 
Our study illustrated the differential trajectories associated with 
episodic memory performance, hippocampal volume, and fMRI 
activation. At baseline, APOE ε4 carriers demonstrate elevated 
functional activation at an earlier stage than non-carriers to 
compensate presumably for accelerated accumulation of neural 
pathology, likely related to AD pathology and possibly neurovascular 
risk factors (see below). The progressive decline in functional 
activation over time reflects reduced compensatory scaffolding 
associated with age-inappropriate episodic memory decline and 
accumulated AD-related pathology as reflected by atrophy of the 
hippocampus. In contrast, APOE ε4 non-carriers demonstrated a 
gradual increase in compensatory task-related brain activation over 
time in the context of age-appropriate changes in episodic memory 
and hippocampal volume, consistent with what would be expected 
based on prior cross-sectional studies (Bangen et al., 2012; Grady, 
2008; Nielson et al., 2002, 2006). 
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The STAC-r model infers that compensatory activation 
responses are predominantly associated with dorsolateral frontal 
regions. This conclusion is derived primarily from fMRI studies that use 
effortful, mostly episodic memory, tasks that engage dorsolateral 
frontal regions. In contrast, we have demonstrated in a series of 
studies (Douville et al., 2005; Nielson et al., 2006, 2010; Seidenberg 
et al., 2009; Smith et al., 2011; Woodard et al., 2009, 2010) that 
compensatory brain activation can occur within non-frontal brain 
regions using the Famous Name Recognition Task, a low effort, high 
accuracy semantic memory task. As noted by Binder et al. (2009), 
there is considerable overlap between the semantic system and the 
default mode network (DMN), whose primary brain regions 
(hippocampus, posterior cingulate, temporoparietal junction, medial 
frontal) are particularly vulnerable to early AD-related 
neuropathological changes (Buckner, 2004). Our results suggest that 
the STAC-r model should be generalized to include compensatory 
processes occurring outside dorsolateral prefrontal regions. 
To our knowledge, there have been no other longitudinal fMRI 
studies comparing cognitively intact older individuals with varying 
genetic risks for AD. However, one study (Smith et al., 2005) 
examined middle-aged women (mean ages = 53 and 54) divided into 
two groups: high genetic risk based on a positive family history of AD 
and possession of an APOE ε4 allele (n=14) and low risk (n=10). 
Changes in brain activation in response to a covert object-naming task 
were measured at baseline and at four-year follow-up. The high risk 
group did not demonstrate greater activation than the low risk group 
at baseline, but showed a greater reduction in brain activation over 
time. These results are difficult to interpret since the covert task used 
in the Smith et al. study yielded no behavioral data to verify that 
participants were in fact performing the task. A decline in activation 
may readily be explained by a lack of task compliance during the 
follow-up scan session. In contrast, the FNRT used in this study was 
performed at a high level of performance at all three scan sessions. 
The APOE ε4 carriers demonstrated a longitudinal decline in 
performance on the RAVLT Delayed Recall measure (see Table 2 and 
Fig. 1), whereas the non-carriers’ performance remained intact and 
stable across the five year interval. We did not expect to see 
performance changes in the Famous Name Recognition Task, which 
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was designed to be performed at greater than 85% accuracy, even in 
patients with amnestic MCI (Woodard et al., 2009). It is important to 
note that most fMRI studies of normal aging employ effortful episodic 
memory tasks whose performance declines with age. It is exceedingly 
difficult to interpret longitudinal fMRI activation maps when task 
performance is also declining. A brain map generated from an 
individual performing at near chance levels will invariably be different 
from a person performing well above chance. Removing incorrect trials 
does not entirely correct the problem because the resulting brain maps 
are generated from a sparse number of correct trials in individuals 
performing near chance. Moreover, the BOLD signals that result from 
greater task difficulty or effort in the poor performing group will be 
inseparable from activation related to memory retrieval-related 
processes, thus confounding any sound interpretation of the activation 
maps (Hantke et al., 2013). 
The APOE ε4 allele is present in approximately 20% of the 
general population (Eichner et al., 2002) and 50% of patients 
diagnosed with AD (Ward et al., 2012). Implicit in our study is the 
assumption that a larger percentage of our APOE ε4 carriers will have 
developed AD-related pathology over the course of the 5-year follow-
up period than the percentage of non-carriers. Although none of our 
participants met the criteria for AD at 5 years, 8 of 24 APOE ε4 carriers 
(33.3%) converted to MCI, whereas only one non-carrier (4.8%) 
converted (p=0.027). To appreciate these results, it is important to 
emphasize that all of our participants were cognitively intact at study 
entry. Long-term prospective studies suggest that the majority of the 
study participants meeting the criteria for MCI will eventually convert 
to AD (Petersen et al., 1999). It is conceivable that additional APOE ε4 
carriers will convert to MCI/AD if examined over a longer follow-up 
interval. The statistically higher percentage of MCI converters among 
the carrier group supports our assumption that our APOE ε4 
participants were more likely to be acquiring AD-related pathology 
than non-carriers. 
One may speculate as to the neuropathological processes that 
result in increased compensatory scaffolding in APOE ε4 carriers at an 
earlier age than non-carriers, followed by diminished scaffolding as 
cognitive performance declines and hippocampal volumes diminish. 
Plausible theories suggest that ε4 disrupts lipid homeostasis, amyloid 
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precursor protein function, and the handling of brain amyloid, 
cholinergic function, and neuroinflammation (Lane and Farlow, 2005; 
Poirier, 2000). Our studies (Smith et al., 2011, 2014) and those of 
others (Head et al., 2012) suggest that the negative effects of 
possessing an ε4 allele on functional and structural imaging may be 
offset by the positive effects of physical activity. Additional work is 
needed to identify the precise mechanisms that underlie the trajectory 
of neural compensation in APOE ε4 carriers. 
It is also possible that the fMRI results could be affected by 
changes in neurovascular coupling associated with AD pathology, 
which is presumed to be greater in the APOE ε4 carriers. Our ASL 
measurements of resting cerebral blood flow at the 5-year follow-up 
session did not reveal group differences in any of the fROIs. 
Furthermore, blood flow did not correlate with fMRI activation in any of 
the fROIs after correction for multiple comparisons. Finally, it is 
possible that our results were related to brain atrophy. However, the 
rate of change in cortical thickness did not differ between the carrier 
and non-carrier groups in any of the fROIs. 
Within the Low Risk group, unexpected positive slopes were 
observed for cortical thickness in the right and left fusiform/lingual gyri 
and the left superior medial gyrus/anterior cingulate. Similar findings, 
however, have been reported in prior neuroimaging studies of normal 
aging. Thambisetty et al. (2010) observed significant longitudinal 
increases in cortical thickness within the left fusiform and lingual gyri. 
Similarly, Salat et al. (2004) observed increases in cortical thickness 
within medial frontal regions, including the anterior cingulate. These 
increases have been attributed to decreases in gray/white matter 
contrast during aging (Thambisetty et al., 2010) and signal dropout 
and anatomical distortions at the base of the brain (Salat et al., 2004). 
Both explanations could potentially lead to distortions in regionally-
specific estimates of cortical thickness. 
In our task-activated fMRI analyses, we chose not to control for 
age since the two groups did not differ statistically in mean age. 
Nevertheless, we conducted a supplementary analysis in which age-
corrected residual scores were generated for the mean fMRI signal 
change for each fROI, participant, and time period and then repeated 
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the LME analyses. Notably, none of the intercept and slope results 
reported in Table 3 changed statistically. 
The current study has its limitations. It is possible that the 
subset of participants who completed all three examination sessions 
are not representative of the entire sample of participants enrolled into 
this longitudinal study. We were unable to identify, however, any 
demographic or baseline neuropsychological or neuroimaging variables 
that differentiated participants who completed the study versus those 
who did not. This study did not use any other imaging biomarkers to 
measure AD-related pathology, such as CSF analyses of tau and 
amyloid proteins or amyloid deposition using PET imaging. The ASL 
measurement of perfusion was only conducted at the 5-year follow-up. 
Finally, the relatively small number of APOE ε4 carriers who converted 
to MCI limited our ability to conduct post-hoc imaging analyses 
comparing converters to non-converters. 
Conclusions 
Compensatory brain activation is commonly seen in the fMRI 
scans of cognitively intact elders. We have demonstrated that this 
compensatory response is accelerated in cognitively intact individuals 
at genetic risk for AD and declines precipitously once cognitive 
dysfunction and hippocampal atrophy become apparent. In contrast, 
elders with a lower risk of developing AD and age-appropriate 
cognition employ increased brain activation to maintain functionality; 
this compensatory response increases with age as long as the low risk 
individual continues to demonstrate age-appropriate cognition. Our 
fMRI results could not be attributed to changes in task performance, 
group differences in cerebral perfusion, or regional cortical atrophy. 
The results provide prospective, empirical evidence of differential 
longitudinal trajectories based on AD risk, supporting the theoretical 
propositions underlying the STAC-r neural compensation theory 
(Reuter-Lorenz and Park, 2014). 
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